Ionization behaviour and tautomerism-dependent lipophilicity of pyridine-2(1H)-one cardiotonic agents

Bioorganic and Medicinal Chemistry

Volumn 8, Issue 5, 2000, Pages 909-916

  Altomare, C ^a   Cellamare, S ^b   Summo, L ^a   Fossa, P ^c   Mosti, L ^c   Carotti, A ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMRINONE; CARDIOTONIC AGENT; MILRINONE; PYRIDINE DERIVATIVE;

ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; DRUG SCREENING; ELECTROPHORESIS; INOTROPISM; IONIZATION; LIPOPHILICITY; MOLECULAR INTERACTION; PH MEASUREMENT; PKA;

CARDIOTONIC AGENTS; ELECTROPHORESIS, CAPILLARY; POTENTIOMETRY; PYRIDONES; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 0034091269     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(00)00025-0     Document Type: Article

References (45)

1. Alousi A.A., Canter J.M., Montenaro M.J., Fort D.J., Ferrari R.A. J. Cardiovasc. Pharmacol. 5:1983;792.
2. Butt E., Beltman J., Becker D.E., Jensen G.S., Rybalkih S.D., Jastorff B., Beavo J.A. Mol. Pharmacol. 47:1995;340.
3. Mosti L., Boggia R., Fossa P. Farmaco. 52:1997;331. and references cited therein.
4. Bristol J.A., Sircar I., Moos W.H., Evans D.B., Weishaar R.E. J. Med. Chem. 27:1984;109.
5. Erhardt P.W., Hagedorn III A.A., Sabio M. Mol. Pharmacol. 33:1988;1.
6. Moos W.H., Humblet C.C., Sircar I., Rithner C., Weishaar R.E., Bristol J.A., McPhail A.T. J. Med. Chem. 30:1987;1963.
7. Erhardt P.W., Chou Y.L. Life Sci. 49:1991;553.
8. Fossa P., Boggia R., Mosti L. J. Comput.-Aided Mol. Design. 12:1998;361.
9. Mosti L., Schenone P., Menozzi G. J. Heterocyclic Chem. 22:1985;1503.
10. Mosti L., Menozzi G., Schenone P., Dorigo P., Gaion R.M., Benetollo F., Bombieri G. Eur. J. Med. Chem. 24:1989;517.
11. Mosti L., Menozzi G., Schenone P., Dorigo P., Gaion R.M., Belluco P. Farmaco. 47:1992;427.
12. Mosti L., Schenone P., Mahiques M.M., Dorigo P., Fraccarollo D., Santostasi G., D'Amico M., Falciani M., Lampa E. Farmaco. 49:1994;559.
13. Baker, R. S.; Crombie, L.; Dove, R. V.; Slack, D. A. J. Chem. Soc., Perkin Trans. 1, 1979, 677.
14. Fossa P., Boggia R., Lo Presti E., Mosti L., Dorigo P., Floreani M. Farmaco. 52:1997;523.
15. Iester, M. PhD. thesis, 1995.
16. Bondavalli F., Bruno O., Lo Presti E., Menozzi G., Mosti L. Synthesis. 7:1999;1169.
17. Ishihama Y., Oda Y., Asakawa N. J. Pharm. Sci. 83:1994;1500.
18. Mrestani Y., Neubert R., Munk A., Wiese M. J. Chromatogr. (A)803:1998;273.
19. Mendonsa S.D., Hurtubise R.J. J. Chromatogr. (A)841:1999;239.
20. Leo, A. In Lipophilicity in Drug Action and Toxicology; Pliska, V.; Testa, B.; van de Waterbeemd, H., Eds.; VCH: Weinheim, 1996; Chap. 9, pp 157-161.
21. Katritzky, A. R.; Rowe, J. D.; Roy, S. K. J. Chem Soc. 1967, (B) 758.
22. Gordon, A.; Katritzky, A. R.; Roy, S. K. J. Chem Soc. 1968, (B) 556.
23. Clark J., Perrin D.D. Quart. Rev. 18:1964;295.
24. Williams S.G., Norrington F.E. J. Am. Chem. Soc. 98:1976;508.
25. van de Waterbeemd, H.; Testa, B. In Advances in Drug Research; Testa, B., Ed.; Academic Press: London, 1987; Vol. 16, pp 85-225.
26. Barlin G.B., Perrin D.D. Quart. Rev. 20:1966;75.
27. Spinner, E.; Yeoh, G. B. J. Chem. Soc. 1971, (B) 279.
28. Spinner, E.; Yeoh, G. B. J. Chem. Soc. 1971, (B) 289.
29. Spinner, E.; Yeoh, G. B. J. Chem. Soc. 1971, (B) 296.
30. Dorigo P., Gaion R.M., Belluco P., Borea P.A., Guerra L., Mosti L., Floreani M., Carpenendo F. Gen. Pharmacol. 23:1992;535.
31. Purcell, W. P.; Bass, G. E.; Clayton, J. M. In Strategy of Drug Design. A Molecular Guide to Biological Activity, App. I. Experimental determination of partition coefficients; Wiley: New York, 1973; pp 126-142.
32. Penfold B.R. Acta Cryst. 6:1953;591.
33. Albert, A.; Phillips, J. N. J. Chem. Soc. 1956, 1294.
34. Mason, S. F. J. Chem. Soc. 1957, 4874.
35. Nakamura K. J. Chem. Soc. Jap. (Pure Chem. Sec.). 80:1959;231.
36. Dorigo P., Gaion R.M., Belluco P., Fraccarollo D., Maragno I., Bombieri G., Benetollo F., Mosti L., Orsini F. J. Med. Chem. 36:1993;2475.
37. Orsini F., Benetollo F., Bombieri G., Mosti L. Eur. J. Med. Chem. 25:1990;425.
38. Orsini F., Benetollo F., Bombieri G., Mosti L. Eur. J. Med. Chem. 28:1993;637.
39. Boggia R., Forina M., Fossa P., Mosti L. Quant. Struct.-Act. Relat. 16:1997;201.
40. -4 M). Milrinone: 38.68±1.25, 46.16±0.80, 52.70±0.83, 52.25±1.13; compound 2: -4.46±0.21, -4.46±0.18, 0.09±0.01, 7.92±0.23 (see ref 30).
41. Wang J., Boyd R.J. J. Phys. Chem. 100:1996;16141.
42. Albert, A.; Serjeant, E. P. In The Determination of Ionization Constants, 3rd edn.; Chapman and Hall: London, 1984; Vol. 4, pp 70-95.
43. Benet L.Z., Goyan J.E. J. Pharm. Sci. 56:1967;665.
44. Lesson L.A., Brown M. J. Pharm. Sci. 55:1966;431.
45. Leo, A. J. In Comprehensive Medicinal Chemistry; Hansch, C.; Sammes, P. G.; Taylor, J. B., Eds.; Pergamon: Oxford, 1990; Vol. 4, pp 295-319.